Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-03-22
2011-03-22
Mi, Qiuwen (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S729000, C424S774000
Reexamination Certificate
active
07910138
ABSTRACT:
A method for treating cancerous or pre-cancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto is described herein.
REFERENCES:
patent: 4002775 (1977-01-01), Kabara
patent: 4248789 (1981-02-01), Okada
patent: 4613672 (1986-09-01), Hara
patent: 4673530 (1987-06-01), Hara
patent: 4863970 (1989-09-01), Patel et al.
patent: 4913909 (1990-04-01), Hara et al.
patent: 4931284 (1990-06-01), Ekman et al.
patent: 5104901 (1992-04-01), Shimamura et al.
patent: 5135957 (1992-08-01), Shimamura
patent: 5137922 (1992-08-01), Shimamura et al.
patent: 5204089 (1993-04-01), Hara et al.
patent: 5306486 (1994-04-01), McCook et al.
patent: 5318986 (1994-06-01), Hara et al.
patent: 5358713 (1994-10-01), Shimamura
patent: 5470565 (1995-11-01), Hayakawa et al.
patent: 5633284 (1997-05-01), Meyer
patent: 5652266 (1997-07-01), Bobler-Rival et al.
patent: 5670154 (1997-09-01), Hara et al.
patent: 5747053 (1998-05-01), Nashimoto et al.
patent: 5766595 (1998-06-01), Yamane et al.
patent: 5795911 (1998-08-01), Cheng et al.
patent: 5804567 (1998-09-01), Cheng et al.
patent: 5807564 (1998-09-01), Shimamura et al.
patent: 5888527 (1999-03-01), Nashimoto et al.
patent: 5910308 (1999-06-01), D'Jang
patent: 5968973 (1999-10-01), Cheng et al.
patent: 6096359 (2000-08-01), Bombardelli et al.
patent: 6127393 (2000-10-01), Fernandez-Pol
patent: 6197808 (2001-03-01), Cheng et al.
patent: 6210679 (2001-04-01), Bailey et al.
patent: 6248346 (2001-06-01), Hara et al.
patent: 6337320 (2002-01-01), Hersh et al.
patent: 6372234 (2002-04-01), Deckers et al.
patent: 6399046 (2002-06-01), Schönrock et al.
patent: 6576660 (2003-06-01), Shutsung et al.
patent: 6596763 (2003-07-01), Thormar et al.
patent: 6696484 (2004-02-01), Liao et al.
patent: 6723750 (2004-04-01), Voet
patent: 2002/0006447 (2002-01-01), Yamazaki et al.
patent: 2002/0031535 (2002-03-01), Sheffield, Sr.
patent: 2002/0151582 (2002-10-01), Dou et al.
patent: 2002/0198161 (2002-12-01), Brash et al.
patent: 2003/0143165 (2003-07-01), Evans et al.
patent: 2003/0166583 (2003-09-01), Hu et al.
patent: 2004/0181130 (2004-09-01), Miller et al.
patent: 2004/0191842 (2004-09-01), Hsu et al.
patent: 2005/0032895 (2005-02-01), Chang et al.
patent: 2005/0079235 (2005-04-01), Stockfleth
patent: 199 62 369 (2001-06-01), None
patent: 0 087 161 (1983-08-01), None
patent: 0 224 457 (1987-06-01), None
patent: 0 573 682 (1993-12-01), None
patent: 0 842 660 (1998-05-01), None
patent: 1 005 862 (2000-06-01), None
patent: WO 98/20872 (1998-05-01), None
patent: WO 99/66897 (1999-12-01), None
patent: WO 00/29027 (2000-05-01), None
patent: WO 00/33832 (2000-06-01), None
patent: WO 01/51048 (2001-07-01), None
patent: WO 2004/026323 (2004-04-01), None
patent: WO 2004/053097 (2004-06-01), None
Wang et al., Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[alpha] anthracene-initiated SKH-1 mice. Cancer Research 54: 3428-3435, 1994.
Zhao et al., Photoprotection in human skin by green tea and black tea. Proceedings of the American Association for Cancer Research 39, 382, 1998.
Katiyar et al., Green tea and skin. Arch Dermatol, 136: 989-994, 2000.
Li et al.,The Chemopreventive Effects of Tea on Human Oral Precancerous Mucosa Lesions, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.), (Apr. 1999) vol. 220, No. 4, pp. 218-224).
Jia et al., Effects of Tea on Preneoplastic Lesions and Cell Cycle Regulators in Rat Liver, Cancer Epidemiology, Biomarkers & Prevention (2002) 11: 1663-1667.
David et al., Novel approaches to chemoprevention of skin cancer, The Journal of Dermatology, 27: 691-695, 2000.
An Kathy et al., Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches, Photochemistry and photobiology, (Jul. 2002) vol. 76, No. 1, pp. 73-80.
Yanaga et al, Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallate, International journal of molecular medicine 10: 311-315, 2002.
Araki et al, Chemoprevention of mammary preneoplasia, In vitro effects of a green tea polyphenol, Annals of the New York Academy of Sciences 768: 215-222, 1995.
Lou et al, Effects of topical applications of caffeine or (-) epigallocatechin gallate (EGCG) on skin carcinogenesis and apoptosis in SKH-1 hairless mice previously treated with ultraviolet B light (high risk mice), Proceedings of the American Association for Cancer Research, 43: 1143, 2002.
Katiyar, Skin photogrotection by green tea: antioxidant and immunomodulatory effects, Current Drug Targets-Immune, Endocrine & Metabolic Disorders, Sep. 3, 2003, 234-242.
Cao, “Angiogenesis Inhibited by Drinking Tea,”Nature, Macmillan Journals Ltd. 398:381 (1999).
Linden et al., “Chemoprevention of Non-Melanoma Skin Cancer: Experience With a Polyphenol From Green Tea,”European Journal of Cancer38:S24 (2002).
Linden et al., “Epigallocatechin Gallate in the Chemoprevention of Non-Melanoma Skin Cancer, With Biomarker Studies of Actinic Keratoses, Sun-Damaged, and Non Sun Damaged Skin: Results of Clinical Trial,”Frontiers of in Cancer Prevention ResearchA113, p. 29 (2003).
McCarty, “Polyphenol-Mediated Inhibition of AP-1 Transactivating Activity May Slow Cancer Growth by Impeding Angiogenesis and Tumor Invasiveness,”Medical Hypothesis50:511-514 (1998).
Mukhtar et al., “Green Tea Polyphenols Induce Apoptoseis and Alter the Progression to Cell Cycle in Human Epidermoid Carcinoma Cells,”Proceedinsg of the American Association for Cancer Research and American Society of Clinical Oncology38:580 (1997).
Proniuk et al., “Preformulation Study of Epigallocatechin Gallate, a Promising Antioxidant for Topical Skin Cancer Prevention,”Journal of Pharmaceutical Sciences91:111-116 (2002).
Zhu et al., “Study of Tea Polyphenol as a Reversal Agent for Carcinoma Cell Lines Multidrug Resistance (Study of TP as a MDR Reversal Agent,”Nuclear Medicine and Biology28:735-740 (2001).
Beutner et al., “Treatment of Genital Warts with an Immune-Response Modifier (Imiquimod),”J. Am. Acad. Dermatol. 38:230-239 (1998).
Ceve, “Drug Delivery Across the Skin,”Exp. Opin. Invest. Drugs6:1887-1937 (1997).
Chemical Abstracts, vol. 80, No. 4, p. 319 (1974).
CIR Compendium 1995, p. 88 (Abstract).
Diding et al., “Isopropyl Myristate as Solvent in Sterility Testing of Petrolatum-Based Ointments,” pp. 616-621 (Chemical Abstract 19503q) (1973).
Edwards et al., “Self-Administered Topical 5% Imiquimod Cream for External Anogenital Warts,”Arch. Dermatol. 134:25-30 (1998).
Garg et al., “Compendium of Pharmaceutical Excipients for Vaginal Formulations,”Pharm. Tech. Drug Deliverypp. 14-24 (2001).
Handbook of Pharmaceutical Excipients, published by American Pharmaceutical Association and the Pharmaceutical Society of Great Britain p. 148 (1986).
Kristmundsdottir et al., “Development and Evaluation of Microbicidal Hydrogels Containing Monoglyceride as the Active Ingredient,”J. Pharm. Sci. 88:1011-1015 (1999).
Sands et al., Extreme Sensitivity of Enveloped Viruses, Including Herpes Simplex, to Long-Chain Unsaturated Monoglycerides and Alcohols,Antimicrobial Agents Chemother. 15:67-73 (1979).
Beutner et al., “Patient-Applied Podofilox for Treatment of Genital Warts,”The Lancet1: 831-834 (1989).
Carter et al., “Drug-Tumor Interactions,”Chemotherapy of Cancer(Second Edition), pp. 361-379 (1981).
Greenberg et al., “A Double-Blind, Randomized Trial of 0.5% Podofilox and Placebo for the Treatment of Genital Warts in Women,”Obstetrics and Gynecology77: 735-739 (1991).
Hara, “Antioxidants in Tea and Their Physiological Functions,”Food and Free Radicals(edited by Hiramatsu et al.), Plenum Press (New Y
Clark & Elbing LLP
Medigene AG
Mi Qiuwen
LandOfFree
Use of a polyphenol for the treatment of a cancerous or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a polyphenol for the treatment of a cancerous or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a polyphenol for the treatment of a cancerous or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2690848